Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Lymph Node Metastasis

phorbol 12,13-dibutyrate has been researched along with Lymph Node Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freeman, JW; Hamby, LS; McGrath, PC	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and Lymph Node Metastasis

Article	Year
Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer. American journal of surgery, 1992, Volume: 164, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cytotoxicity Tests, Immunologic; Head and Neck Neoplasms; Humans; Immunotherapy, Adoptive; Ionomycin; Lymph Nodes; Lymphatic Metastasis; Lymphocyte Activation; Phorbol 12,13-Dibutyrate; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured	1992

Article

Year

Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.

American journal of surgery, 1992, Volume: 164, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cytotoxicity Tests, Immunologic; Head and Neck Neoplasms; Humans; Immunotherapy, Adoptive; Ionomycin; Lymph Nodes; Lymphatic Metastasis; Lymphocyte Activation; Phorbol 12,13-Dibutyrate; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured

1992